Skip to main content
TipRanks
Go Ultimate75% OFF

Micheal Bradfield Insider Profile

4 Followers

Micheal Bradfield, former Director at Advanced Oncotherapy, holds 8.35M shares in Advanced Oncotherapy (Ticker: GB:AVO). Most recently, Micheal Bradfield Bought 500,000 shares of Advanced Oncotherapy on Dec 30, 2022 for an estimated value of 65.85K .

Micheal Bradfield's Trading History

AVO
Advanced Oncotherapy
Dec 30, 2022―Informative Buy65.85K£146.20K
GB:AVO
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 30, 2022Informative Buy£65.85K500,000£13.00-87.00%―
Aug 03, 2022Uninformative Buy£74.00K296,000£25.00――
Aug 11, 2021Uninformative Buy£46.00K115,000£40.00――
Oct 26, 2020Uninformative Buy£75.00K250,000£30.00――
Aug 07, 2019Uninformative Buy£45.00K112,500£40.00――

You May Also Like

Micheal Bradfield insider profile FAQ

What is the percentage of profitable transactions made by Micheal Bradfield?
The percentage of profitable transactions made by Micheal Bradfield is 25%.
What is the average return per transaction made by Micheal Bradfield?
The average return per transaction made by Micheal Bradfield is -9.40%.
What stocks does Micheal Bradfield hold?
Micheal Bradfield holds: GB:AVO stocks.
What was Micheal Bradfield’s latest transaction?
Micheal Bradfield’s latest transaction was an Informative Buy of 65.85K .
What was Micheal Bradfield's most profitable transaction?
Micheal Bradfield’s most profitable transaction was an Informative Buy of GB:AVO stock on April 17, 2014. The return on the trade was 418.10%.
What is Micheal Bradfield's role in Advanced Oncotherapy?
Micheal Bradfield's role in Advanced Oncotherapy is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.